Unbiased AI-powered news
1 stories related to this topic, newest first.
app.buzzsumo.comTris Pharma announced five presentations on cebranopadol at the College on Problems of Drug Dependence meeting. The sessions will cover preclinical and clinical data on the drug's effects in pain and opioid use disorder.